Skip to main content

Table 3 Fasted levels of metabolic blood markers in STZ-treated hyperglycemic, STZ-treated euglycemic, and vehicle-treated control rats

From: Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia

 

Control

STZ, Euglycemic

STZ, Hyperglycemic

Factor

2 Weeks

8 Weeks

2 Weeks

8 Weeks

2 Weeks

8 Weeks

Glucose (mM)

7.0 ± 1.2

6.3 ± 0.4

7.0 ± 1.1

5.9 ± 0.6

24.6 ± 7.2*†

28.8 ± 5.1*†

Insulin (ng/mL)

0.65 ± 0.41

1.36 ± 0.69

0.67 ± 0.66

0.79 ± 0.57

0.78 ± 0.46

0.33 ± 0.33*†

NEFA (nM)

0.20 ± 0.10

0.40 ± 0.13

0.31 ± 0.05

0.20 ± 0.12*

0.30 ± 0.22

0.24 ± 0.14*

Triglyceride (nM)

0.79 ± 0.05

0.81 ± 0.35

0.67 ± 0.17

0.66 ± 0.14

0.80 ± 0.45

0.55 ± 0.29*

NE (ng/mL)

0.10 ± 0.05

0.11 ± 0.06

0.10 ± 0.14

0.10 ± 0.03

0.10 ± 0.06

0.24 ± 0.09*†

  1. Mean ± SD.
  2. * p < 0.05 to age-matched control, † p < 0.05 to age-matched STZ, euglycemic, one-way ANOVA, Bonferroni post hoc
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840